Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR0890) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Isotretinoin
|
|||||
Synonyms |
Isotretinoin; Isotretinoin (USP); Isotretinoine; Isotretinoine [INN-French]; Isotretinoino [INN-Spanish]; Isotretinoinum; Isotretinoinum [INN-Latin]; Isotrex; Neovitamin A acid; RETINOIC ACID, 13-cis-; Ro-4-3780; Roaccutan; Roaccutane; Roacutan; Amnesteem; CIP-Isotretinoin; Claravis; ISOTRETINON; Sotret; Teriosal; isotretinoino; (13cis)-retinoic acid; 13-RA; 13-cis RA; 13-cis retinoic acid; 13-cis-Retinoic acid; 13-cis-Vitamin A acid; 4759-48-2; Absorica; Accutane; Accutane (TN); CCRIS 4286; EINECS 225-296-0; HSDB 3929; UNII-EH28UP18IF
|
|||||
Indication | Acne vulgaris [ICD11: ED80] | Approved | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 300.4 | Topological Polar Surface Area | 37.3 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
Cross-matching ID |
|
|||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
References | ||||||
---|---|---|---|---|---|---|
1 | Tretinoin was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration. | |||||
2 | Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids | |||||
3 | The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther. 2004 May;75(5):464-75. | |||||
4 | The use of isotretinoin in acne Dermatoendocrinol. 2009 May;1(3):162-9. doi: 10.4161/derm.1.3.9364. | |||||
5 | Human biliary metabolites of isotretinoin: identification, quantification, synthesis, and biological activity Xenobiotica. 1990 Feb;20(2):193-207. doi: 10.3109/00498259009047155. | |||||
6 | Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic Drug Metab Dispos. 2022 Jul;50(7):1042-1052. doi: 10.1124/dmd.122.000882. | |||||
7 | DrugBank(Pharmacology-Metabolism)Isotretinoin |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.